Discovery of protein-protein binding disruptors using multi-component condensations small molecules.
A series of small molecule compounds interfering with the binding process of VEGF and NRP1 has been identified and further optimized. Full synthetic details as well as SAR are reported which demonstrate that expeditious MCC-based syntheses may lead to valuable molecules addressing challenging targets such as protein-protein interactions. Preliminary functional assay data confirm that these compounds may be further developed toward drug candidates.
Bedjeguelal
Karim
K
Pierre Fabre Urologie, 11 Av. Albert Einstein, 69100 Villeurbanne, France.
Bienaymé
Hugues
H
Dumoulin
Antoine
A
Poigny
Stéphane
S
Schmitt
Philippe
P
Tam
Eric
E
D002460:Cell Line; D039942:Neuropilin-1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011485:Protein Binding; D013329:Structure-Activity Relationship; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors* / Q000378:metabolism
D042461:Vascular Endothelial Growth Factor A; D039942:Neuropilin-1